Ontology-Driven Hypothetic Assertion (OHA) for drug interaction prediction

Proceedings - 2nd International Multi-Symposiums on Computer and Computational Sciences, IMSCCS'07

Volumn , Issue , 2007, Pages 1-8

  Arikuma, Takeshi ^a   Yoshikawa, Sumi ^b   Watanabe, Kentaro ^a   Matsumura, Kazumi ^b   Konagaya, Akihiko ^b  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

Biomedical ontology; Drug interaction; Metabolic pathway; Pharmacokinetics; Web Ontology Language (OWL)

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; FLOW INTERACTIONS; FORECASTING; HEALTH; MINE FLOODING; MOLECULES; ONTOLOGY;

ALBUMIN (ALB); AMOUNT OF INFORMATION; COMPUTATIONAL SCIENCES; CYTOCHROME P450 (CYP); DRUG DRUG INTERACTIONS; DRUG RESPONSE; EXPONENTIAL NUMBERS; IN-SILICO; INDIVIDUAL DIFFERENCES; INFORMATION MODELLING; INTERNATIONAL (CO); IRINOTECAN; KETOCONAZOLE; METABOLIC PATHWAYS; MOLECULAR EVENTS; POTENTIAL DRUGS; REAL WORLD; WEB ONTOLOGY LANGUAGE (OWL);

DRUG INTERACTIONS;

EID: 46449134860     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IMSCCS.2007.4392573     Document Type: Conference Paper

References (31)

1. H. Okuda, K. Ogura, A. Kato, H. Takubo, and T. Watanabe, "A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs, " J Pharmacol Exp Ther 1998, 287(2), pp. 791-99
2. Baker, Christopher J.O.; Cheung, Kei-Hoi (Eds.); Semantic Web: Revolutionizing Knowledge Discovery in the Life Sciencesi, Springer, (2007).
3. Tsukamoto Y, Kato Y, Ura M, Horii I, Ishitsuka H, Kusuhara H, Sugiyama Y.,A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans, the mechanism for tumor-selective accumulation of 5-FU. , Pharm Res., 18(8), pp. 1190-202 (2001)
4. Michaela Vossen, Michael Sevestre, Christoph Niederalt, In-Jin Jang, Stefan Willmann, and Andrea N Edginton, Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WBPBPK) models, Theor Biol Med Model. 2007; 4, pp. 13.
5. OWL Web Ontology Language Reference. http://www.w3.org/tr/owl-ref/.
6. Sumi Yoshikawa, Satou K, and Konagaya A. DIO for inferences of possible drug-drug interactions. Medinfo., 11(1), pp. 454-458, 2004.
7. Sumi Yoshikawa, Satou Kenji, and Akihiko Konagaya. Application of DIO for possible drug-drug interactions. In Proceedings of Chemi BioInformatics Society Year 2003, page 320, 2003
8. Berners-Lee, T., J. Hendler, and O. Lassila, The Semantic Web. Scientific American, 2001. 284(5), pp. 34-43.
9. Pierre Grenon and Barry Smith. Snap and span: Towards dynamic spatial ontology. Spatial Cognition and Computation, 1, pp. 69-103, 2004.
10. Pierre Grenon, Barry Smith, and Louis Goldberg. Biodynamic ontology: applying BFO in the biomedical domain. In Ontologies in Medicine, pages 20-38. Amsterdam, IOS Press, 2004.
11. M. Kanehisa and S. Goto. Kegg, Kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 28, pp. 27-30, 2000.
12. Diedrik F.S. Kehrer, Ron H.J. Mathijssen, Jaap Verweij, Peter de Bruijn, and Alex Sparreboom. Modulation of irinotecan metabolism by ketoconazole. Journal of Clinical Oncology, 20(14), pp. 3122-3129, July 2002.
13. N. Noy, R. Fergerson, and M. Musen. The knowledge model of Prot'eg'e-2000, Combining interoperability and flexibility. In R. Dieng and O. Corby, editors, Proc. of the 12th EKAW, LNAI, pages 17.32, Juan-les-Pins, France, 2000. Springer.
14. Lisa Bomgaars, Stacey L. Berg, and Susan M. Blaney. The development of camptothecin analogs in childhood cancers. The Oncologist, 6, pp. 506-516, 2001.
15. Tawfique K. Daneshmend and David W. Warnock. Clinical pharmacokinetics of ketoconazole. Clinical Pharmacokinetics, 14, pp. 13-34, 1988.
16. Ron H. J. Mathijssen, Robbert J. van Alphen, Jaap Verweij, Walter J. Loos, Kees Nooter, Gerrit Stoter, and Alex Sparreboom. Clinical pharmacokinetics and metabolism of irinotecan (cpt-11). Clinical Cancer Research, 7, pp. 2182-2194,8 2001.
17. Rosita J. Rodriguez, Philip J. Proteau, Brian L. Marquez, Craig L. Hetherington, Cheryl J. Buckholz, and Kerry L. O'connell. Flavin-containing monooxygenasemediated metabolism of n-deacetyl ketoconazole by rat hepatic microsomes. Drug Metabolism and Disposition, 27(8), pp. 880-886, 1999.
18. Rosita J. Rodriguez and Daniel Jr Acosta. N-deacetyl ketoconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. Toxicology, 117, pp. 123-131, 1997.
19. Robert H. Tukey, Christian P. Strassburg, and Peter I. Mackenzie. Pharmacogenomics of human udpglucuronosyltransferases and irinotecan toxicity. Molecular Pharmacology, 62(3), pp. 446-450, 2002.
20. Rocio Garcia-Carbonero and Jeffrey G. Supko. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clinical Cancer Research, 8, pp. 641-661, 2002.
21. Nozawa T, Minami H, Sugiura S, Tsuji A, and Tamai I. Role of organic anion transporter oatplbl (oatp-c) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: in vitro evidence and effect of single nucleotide polymorphisms. Drug metabolism and disposition: the biological fate of chemicals., 33(3), pp. 434-439, 11 2004.
22. R.C. Heel, R.N. Brogden, P.A. Morley A. Carmine, T.M. Speight, and G.S. Avery. Ketoconazole: A review of its therapeutic efficacy in superficial and systemic funfal infections. Drugs, 23, pp. 1-36, 1982.
23. 25O1ivier Bodenreider. The unified medical language system (umls): integrating biomedical terminology. Nucleic Acids Research, 32, pp. D267-D270, 1 2004.
24. 26Cornelius Rosse and Jose L. V. Mejino. A reference ontology for biomedical informatics: the foundational model of anatomy. Journal of Biomedical Informatics, 36, pp. 478-500, 2003.
25. Christine Golbreich, Songmao Zhang, and Oliver Bodenreider. The foundational model of anatomy in owl: Experience and perspectives. Journal of Web Semantics, 4, pp. 181-195, 2006.
26. Barry Smith, Werner Ceusters, Bert Klagges, Jacob Kohler, Anand Kumar, Jane Lomax, Chris Mungall, Fabian Neuhaus, Alan L Rector, and Cornelius Rosse. Relations in biomedical ontologies. Genome Biology, 6, pp. R46, 2005.
27. Wielemaker, J., SWI-Prolog 5.6 eference Manual, Updated for version 5.6.32, March 2007, Amsterdam (2007).
28. Emden R. Gansner and Stephen C. North. An open graph visualization system and its applications to software engineering. Software. Practice and Experience, 30(11), pp. 1203-1233, 2000.
29. Michiharu Kageyama, Hitomi Namiki, Hiroto Fukushima, Yukako Ito, Nobuhito Shibata and Kanji Takada, "In Vivo Effects of Cyclosporin A and Ketoconazole on the Pharmacokinetics of Representative Substrates for P-Glycoprotein and Cytochrome P450 (CYP) 3A in Rats", Biol. Pharm. Bull., Vol. 28, 316-322 (2005).
30. Mitsuhiro Okada , Yutaro Sugimoto , Sumi Yoshikawa, and Akihiko Konagaya, DIO and the Resource-Sensitive Logical Inferences , Lecture Notes in Computer Science,pp.616-642,2006
31. Konagaya Akihiko, Azuma R, Umetsu R, Ohki S, Konishi F, Matsumura K, and Yoshikawa S. Parameter mining: Discovery of dynamical characteristics using geometrical patterns of parameter-parameter dependencies on differential equations. In Proceedings of the LSGRID2006, Yokohama, pages 137-152, October 2006.